These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34711630)

  • 1. Taming the Wild-Type Gastrointestinal Stromal Tumor: Improved Tissue Culture.
    Blakely AM; Glod JW; Wedekind Malone MF
    Clin Cancer Res; 2022 Jan; 28(1):3-4. PubMed ID: 34711630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quadruple wild-type (WT) GIST: defining the subset of GIST that lacks abnormalities of KIT, PDGFRA, SDH, or RAS signaling pathways.
    Pantaleo MA; Nannini M; Corless CL; Heinrich MC
    Cancer Med; 2015 Jan; 4(1):101-3. PubMed ID: 25165019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Subtypes of KIT/PDGFRA Wild-Type Gastrointestinal Stromal Tumors: A Report From the National Institutes of Health Gastrointestinal Stromal Tumor Clinic.
    Boikos SA; Pappo AS; Killian JK; LaQuaglia MP; Weldon CB; George S; Trent JC; von Mehren M; Wright JA; Schiffman JD; Raygada M; Pacak K; Meltzer PS; Miettinen MM; Stratakis C; Janeway KA; Helman LJ
    JAMA Oncol; 2016 Jul; 2(7):922-8. PubMed ID: 27011036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of IGF-1 receptor in KIT/PDGF receptor-α wild-type gastrointestinal stromal tumors with succinate dehydrogenase complex dysfunction.
    Nannini M; Astolfi A; Paterini P; Urbini M; Santini D; Catena F; Indio V; Casadio R; Pinna AD; Biasco G; Pantaleo MA
    Future Oncol; 2013 Jan; 9(1):121-6. PubMed ID: 23252569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastrointestinal stromal tumors - Summary of mutational status of the primary/secondary KIT/PDGFRA mutations, BRAF mutations and SDH defects.
    Kalfusova A; Linke Z; Kalinova M; Krskova L; Hilska I; Szabova J; Vicha A; Kodet R
    Pathol Res Pract; 2019 Dec; 215(12):152708. PubMed ID: 31708372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Establishment of Patient-Derived Succinate Dehydrogenase-Deficient Gastrointestinal Stromal Tumor Models for Predicting Therapeutic Response.
    Yebra M; Bhargava S; Kumar A; Burgoyne AM; Tang CM; Yoon H; Banerjee S; Aguilera J; Cordes T; Sheth V; Noh S; Ustoy R; Li S; Advani SJ; Corless CL; Heinrich MC; Kurzrock R; Lippman SM; Fanta PT; Harismendy O; Metallo C; Sicklick JK
    Clin Cancer Res; 2022 Jan; 28(1):187-200. PubMed ID: 34426440
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defects in succinate dehydrogenase in gastrointestinal stromal tumors lacking KIT and PDGFRA mutations.
    Janeway KA; Kim SY; Lodish M; Nosé V; Rustin P; Gaal J; Dahia PL; Liegl B; Ball ER; Raygada M; Lai AH; Kelly L; Hornick JL; ; O'Sullivan M; de Krijger RR; Dinjens WN; Demetri GD; Antonescu CR; Fletcher JA; Helman L; Stratakis CA
    Proc Natl Acad Sci U S A; 2011 Jan; 108(1):314-8. PubMed ID: 21173220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KIT mutation in a naïve succinate dehydrogenase-deficient gastric GIST.
    Brcic I; Kashofer K; Skone D; Liegl-Atzwanger B
    Genes Chromosomes Cancer; 2019 Nov; 58(11):798-803. PubMed ID: 31124195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal Stromal Tumors: The GIST of Precision Medicine.
    Mei L; Smith SC; Faber AC; Trent J; Grossman SR; Stratakis CA; Boikos SA
    Trends Cancer; 2018 Jan; 4(1):74-91. PubMed ID: 29413424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification of KIT/PDGFRA wild-type gastrointestinal stromal tumors: implications for therapy.
    Huss S; Elges S; Trautmann M; Sperveslage J; Hartmann W; Wardelmann E
    Expert Rev Anticancer Ther; 2015 Jun; 15(6):623-8. PubMed ID: 25831232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular alterations and expression of succinate dehydrogenase complex in wild-type KIT/PDGFRA/BRAF gastrointestinal stromal tumors.
    Celestino R; Lima J; Faustino A; Vinagre J; Máximo V; Gouveia A; Soares P; Lopes JM
    Eur J Hum Genet; 2013 May; 21(5):503-10. PubMed ID: 22948025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of all subunits, SDHA, SDHB, SDHC, SDHD, of the succinate dehydrogenase complex in KIT/PDGFRA wild-type GIST.
    Pantaleo MA; Astolfi A; Urbini M; Nannini M; Paterini P; Indio V; Saponara M; Formica S; Ceccarelli C; Casadio R; Rossi G; Bertolini F; Santini D; Pirini MG; Fiorentino M; Basso U; Biasco G;
    Eur J Hum Genet; 2014 Jan; 22(1):32-9. PubMed ID: 23612575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Succinate dehydrogenase deficiency in a PDGFRA mutated GIST.
    Belinsky MG; Cai KQ; Zhou Y; Luo B; Pei J; Rink L; von Mehren M
    BMC Cancer; 2017 Aug; 17(1):512. PubMed ID: 28768491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SDHA loss of function mutations in a subset of young adult wild-type gastrointestinal stromal tumors.
    Italiano A; Chen CL; Sung YS; Singer S; DeMatteo RP; LaQuaglia MP; Besmer P; Socci N; Antonescu CR
    BMC Cancer; 2012 Sep; 12():408. PubMed ID: 22974104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of insulin-like growth factor 1 receptor and frequent mutational inactivation of SDHA in wild-type SDHB-negative gastrointestinal stromal tumors.
    Belinsky MG; Rink L; Flieder DB; Jahromi MS; Schiffman JD; Godwin AK; von Mehren M
    Genes Chromosomes Cancer; 2013 Feb; 52(2):214-24. PubMed ID: 23109135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Good survival outcome of metastatic SDH-deficient gastrointestinal stromal tumors harboring SDHA mutations.
    Pantaleo MA; Lolli C; Nannini M; Astolfi A; Indio V; Saponara M; Urbini M; La Rovere S; Gill A; Goldstein D; Ceccarelli C; Santini D; Rossi G; Fiorentino M; Di Scioscio V; Fusaroli P; Mandrioli A; Gatto L; Catena F; Basso U; Ercolani G; Pinna AD; Biasco G
    Genet Med; 2015 May; 17(5):391-5. PubMed ID: 25188872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Duodenal SDH-Deficient Gastrointestinal Stromal Tumor in a Patient With a Germline SDHB Mutation.
    Elston MS; Sehgal S; Dray M; Phillips E; Conaglen JV; Clifton-Bligh RJ; Gill AJ
    J Clin Endocrinol Metab; 2017 May; 102(5):1447-1450. PubMed ID: 28324028
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gain of FGF4 is a frequent event in KIT/PDGFRA/SDH/RAS-P WT GIST.
    Urbini M; Indio V; Tarantino G; Ravegnini G; Angelini S; Nannini M; Saponara M; Santini D; Ceccarelli C; Fiorentino M; Vincenzi B; Fumagalli E; Casali PG; Grignani G; Pession A; Ardizzoni A; Astolfi A; Pantaleo MA
    Genes Chromosomes Cancer; 2019 Sep; 58(9):636-642. PubMed ID: 30887595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrating miRNA and gene expression profiling analysis revealed regulatory networks in gastrointestinal stromal tumors.
    Pantaleo MA; Ravegnini G; Astolfi A; Simeon V; Nannini M; Saponara M; Urbini M; Gatto L; Indio V; Sammarini G; Santini D; Ferracin M; Negrini M; Hrelia P; Biasco G; Angelini S
    Epigenomics; 2016 Oct; 8(10):1347-1366. PubMed ID: 27625077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic SDH-Deficient GIST Diagnosed during Pregnancy: Approach to a Complex Case.
    Chennouf A; Zeidan E; Borduas M; Noël-Lamy M; Kremastiotis J; Beaudoin A
    Curr Oncol; 2022 Aug; 29(8):5933-5941. PubMed ID: 36005206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.